Antti J. Tanskanen

Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 244 publications

Real-world effectiveness of psychiatric pharmacotherapies in reducing the risk of substance use- and psychiatric hospitalisations in cannabis use disorder - an exploratory nationwide register-based study.

Real-world effectiveness of psychiatric pharmacotherapies in reducing the risk of substance use- and psychiatric hospitalisations in cannabis use disorder - an exploratory nationwide register-based study.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: August 12, 2026

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Journal: Acta psychiatrica Scandinavica

Published: February 14, 2026

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Journal: Acta psychiatrica Scandinavica

Published: February 13, 2026

Correction to: Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study.

Correction to: Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study.

Journal: European journal of clinical pharmacology

Published: January 27, 2026

Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study.

Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register-based study.

Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)

Published: January 15, 2026

Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up - ADDENDUM.

Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up - ADDENDUM.

Journal: BJPsych open

Published: December 18, 2025

PRE2DUP-R, advanced, open science method to estimate drug use periods for pharmacoepidemiology.

PRE2DUP-R, advanced, open science method to estimate drug use periods for pharmacoepidemiology.

Journal: International journal of medical informatics

Published: December 16, 2025

Comparative Clinical Trajectories Across Cannabis-Related and Nonsubstance-Related Psychoses.

Comparative Clinical Trajectories Across Cannabis-Related and Nonsubstance-Related Psychoses.

Journal: Acta psychiatrica Scandinavica

Published: November 27, 2025

Optimizing antipsychotic dosing for relapse prevention in cannabis-induced psychosis: A nationwide cohort study.

Optimizing antipsychotic dosing for relapse prevention in cannabis-induced psychosis: A nationwide cohort study.

Journal: Psychiatry research

Published: November 14, 2025

Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study.

Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study.

Journal: The lancet. Psychiatry

Published: October 06, 2025

Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study.

Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study.

Journal: BMJ mental health

Published: September 20, 2025

Long-Term Use of Benzodiazepines and Related Drugs in Persons With Major Depressive Disorder.

Long-Term Use of Benzodiazepines and Related Drugs in Persons With Major Depressive Disorder.

Journal: Brain and behavior

Published: August 08, 2025

Showing 1-12 of 244

Last Updated: 09/26/2026